AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesInformation ScienceNamed GroupsHealth Care
Hepatitis B Core AntigensHepatitis B AntibodiesHepatitis BHepatitis B Surface AntigensHepatitis B virusHepatitis B AntigensHepatitis B e AntigensHepatitis B VaccinesHepatitis B, ChronicHepatitis CBlood DonorsCarrier StateDNA, ViralHepatitis AntibodiesAntibodies, ViralHepatitis, ChronicImmunoglobulin MRadioimmunoassaySeroepidemiologic StudiesImmunoenzyme TechniquesHepatitis C AntibodiesLiverEpitopesHepatitis AAntibodiesEnzyme-Linked Immunosorbent AssayLiver CirrhosisHepatitis, Viral, HumanAntigensHepatitis C AntigensPrevalenceLamivudineViral Core ProteinsChronic DiseaseAntibody SpecificityHepatitis C, ChronicHepatitisAcute DiseaseHepacivirusAntiviral AgentsAntibodies, MonoclonalMolecular Sequence DataHepatitis VirusesAntigens, ViralHepatitis A virusAntigens, BacterialAntibodies, BacterialHepatitis B Virus, DuckLiver TransplantationCarcinoma, HepatocellularHepatitis, Viral, AnimalRisk FactorsAntibody FormationViral Hepatitis VaccinesLiver NeoplasmsAntigens, SurfaceAntigens, NeoplasmImmunoglobulin GHepatitis A VaccinesTissue Donors
HBsAgHBeAgHBcAgHBcAbPrevalenceVaccinationViralAnti-HBsSurface antigensTotal antibodyHBsAbNative Antigen CompanyVirus Core antibodyVaccinesVirusesHepatocellular carcinomaImmune globulinCirrhosis and liver cancerInfectionsSerologicMonoclonal antibodyRisk of hepatitisDiagnosisSymptomsCaused by the hepatitis B virAsymptomaticDonorChronic infectionJaundiceIncidenceProteinsFulminant hepatitisMarkersInflammationHDAgAssayDosesRibonucleic acidCases of acuteClinicalSpecificityLiver diseasePatients with chronicInfectiousWorld health OrganAntiviralTransmissionNeonatalStages of hepatitisPeople with hepatitisVaccine against hepatitisAdults
HBsAg24
  • This involves the simultaneous reaction of HBsAg in the sample with mouse monoclonal anti-HBs antibody coated onto the wells and a horseradish peroxidase (HRP)-labeled mouse monoclonal anti-HBs antibody in the conjugate. (cdc.gov)
  • Therefore, laboratory diagnosis is undertaken using serological and molecular methods to detect HBsAg and specific IgM antibodies recognising core antigen HbcAg. (thenativeantigencompany.com)
  • We determined the serum level of antibody to hepatitis B surface antigen (anti-HBsAg) in 273 randomly selected 7-9-year-old schoolchildren from Zanjan City, Islamic Republic of Iran, who had been fully vaccinated against hepatitis B starting at birth. (who.int)
  • A "positive" or "reactive" HBsAg test result means that the person is infected with the hepatitis B virus, which can be an "acute" or a "chronic" infection. (hepb.org)
  • This result (along with a negative HbsAg result) means that you are immune to (protected from) a future hepatitis B infection. (hepb.org)
  • The laboratory diagnosis focuses on the detection of the hepatitis B surface antigen HBsAg. (apollohospitals.com)
  • Acute HBV infection is accompanied by the presence of HBsAg and immunoglobulin M (IgM) antibody to the core antigen, HBcAg. (apollohospitals.com)
  • Testing for hepatitis B surface antigen (HbsAg) and antibody to hepatitis B core antigen (anti-HBc) was positive and PCR test for HBV DNA showed a low viral load. (hindawi.com)
  • Sera were screened for hepatitis B surface antigen (HBsAg), antibody to hepatitis B core antigen (anti-HBc) and hepatitis B e antigen (HBeAg). (bmj.com)
  • Test all patients for evidence of current or prior HBV infection by measuring hepatitis B surface antigen (HBsAg) and hepatitis B core antibody (anti-HBc) before initiating HCV treatment with DAKLINZA [see WARNINGS AND PRECAUTIONS ]. (rxlist.com)
  • When limited to institutes at which almost all (≥ 90%) patients were tested for HBV serology, 1.1% (40/3,580) patients with RA and 0.3% (3/1,128) patients with SLE were positive for hepatitis B surface antigen (HBsAg), and 25.2% (177/703) patients with RA and 13.7% (34/248) patients with SLE were positive for hepatitis B core antibody (HBcAb). (go.jp)
  • About one-third of rheumatologists did not check HBsAg and more than half did not check hepatitis B surface antibody (HBsAb) or HBcAb at all before therapy. (go.jp)
  • The hepatitis B surface antigen (HBsAg) test is used to detect the presence of hepatitis B surface antigens in your blood. (metropolisindia.com)
  • The HBsAg test is usually performed as part of a panel of tests, such as the hepatitis B panel, which also includes tests for other hepatitis viruses. (metropolisindia.com)
  • Your doctor may recommend the HBsAg test if you have symptoms of acute hepatitis B, such as fatigue, fever, abdominal pain, dark urine, or yellowing of your skin or eyes ( jaundice ). (metropolisindia.com)
  • If the HBsAg test is positive, it means that you have a chronic hepatitis B infection and require treatment. (metropolisindia.com)
  • The HBsAg test is used to screen for hepatitis B infection and to help diagnose acute or chronic hepatitis B. This test can also be used to monitor people who are at risk for hepatitis B infection, such as people with HIV or those who have been exposed to the virus. (metropolisindia.com)
  • The HBsAg test is used to diagnose hepatitis B, determine if you are a carrier of the virus, and monitor the effectiveness of treatment for hepatitis B. (metropolisindia.com)
  • The HBsAg test is usually done as part of a panel of tests for hepatitis B. Other tests in this panel may include the hepatitis B core antibody (HBcAb) and the hepatitis B surface antibody (HBsAb). (metropolisindia.com)
  • We recommend testing all patients undergoing cancer treatment for hepatitis B (including HBV surface antigen [HBsAg], HBV core antibody [anti-HBc], and HBV surface antibody) before cancer treatment. (monash.edu)
  • RESULTS: A total of 316 (88%) had been tested for anti-HCV antibody, 244 (68%) had been tested for anti hepatitis B core antibody (anti-HBc), 299 (84%) had been tested for hepatitis B surface antigen (HBsAg) and 307 (86%) had been tested for anti-HIV antibody. (drugsandalcohol.ie)
  • Routine screening of donor blood for hepatitis B surface antigen (HBsAg) has nearly eliminated the previously common posttransfusion transmission, but transmission through needles shared by drug users remains common. (msdmanuals.com)
  • The 2010 targets of the China Hepatitis B Prevention Programme were a prevalence of hepatitis B surface antigen (HBsAg) less than 1.0% for children less than five years old and less than 6.0% for the total population. (who.int)
  • For example, a hepatitis B surface antigen (HBsAg) level of less than 1 s/c is considered negative, while a level more than 5 s/c is considered positive. (medscape.com)
HBeAg3
  • Hepatitis B type e antigen (HBeAg). (healthlinkbc.ca)
  • During the initial phase of infection, patients are also seropositive for hepatitis B e antigen (HBeAg). (apollohospitals.com)
  • Proposed cutoffs for consideration for antiviral therapy is 100,000 copies/mL or 20,000 IU/mL in HbeAg-positive patients with chronic hepatitis and 10,000 copies/mL or 2,000 IU/mL in HbeAg-negative patients. (medscape.com)
HBcAg5
  • This involves the reaction of anti-HBc in the sample with hepatitis B core antigen (HBcAg) coated wells. (cdc.gov)
  • Horseradish peroxidase (HRP)-labeled antibody conjugate (mouse monoclonal anti-HBc) is then allowed to react with the remaining exposed HBcAg on the well surface. (cdc.gov)
  • Anonymous and unlinked blood samples of 230 pregnant women delivered between the period of March 1998 and October, 1999 at the Jos University Teaching Hospital (JUTH), Jos, Nigeria were tested for HIV-1 and total antibody to Hepatitis B virus core antigen (HBcAg). (ajol.info)
  • The presence of HBcAg antibody was unrelated to age, parity, marital status, level of education, or history of previous jaundice or blood transfusion. (ajol.info)
  • Infant birth weight in the index delivery was not affected by the HBcAg antibody status. (ajol.info)
HBcAb1
  • Hepatitis B IgM core antibody (HBcAb-IgM) and IgG core antibody (HBcAb-IgG). (healthlinkbc.ca)
Prevalence15
Vaccination17
  • ABSTRACT The duration of protection after hepatitis B vaccination in children is unknown. (who.int)
  • In 1991, the World at least 6-8 years before with 3 doses of Health Organization (WHO) recommended hepatitis B vaccine starting at birth to that hepatitis B vaccination be included provide information on the effect of the in national immunization programmes in immunization strategy for hepatitis B and countries with a hepatitis B surface antigen the need for booster doses. (who.int)
  • It has been reported that when hepatitis services is good throughout the territory, B vaccination is initiated at birth, there and vaccinations are delivered through local is an increased likelihood that the child health districts which are able to reach the will complete the series [ 8,9 ] hence an whole population. (who.int)
  • Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV) infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and death. (cdc.gov)
  • This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection. (cdc.gov)
  • In settings in which a high proportion of adults have risks for HBV infection (e.g., sexually transmitted disease/human immunodeficiency virus testing and treatment facilities, drug-abuse treatment and prevention settings, health-care settings targeting services to IDUs, health-care settings targeting services to MSM, and correctional facilities), ACIP recommends universal hepatitis B vaccination for all unvaccinated adults. (cdc.gov)
  • To promote vaccination in all settings, health-care providers should implement standing orders to identify adults recommended for hepatitis B vaccination and administer vaccination as part of routine clinical services, not require acknowledgment of an HBV infection risk factor for adults to receive vaccine, and use available reimbursement mechanisms to remove financial barriers to hepatitis B vaccination. (cdc.gov)
  • Hepatitis B infection has been preventable by vaccination since 1982. (wikipedia.org)
  • In 1993, 495 additional samples from participants with a medical occupation who were negative for antibody to hepatitis core antigen were tested to determine mIU/ml of antibody to assess vaccination status. (cdc.gov)
  • Results of the serum hepatitis B surface antibody can not be used to estimate the vaccination status of the U.S. population since all participants were not tested for this serologic marker. (cdc.gov)
  • A total of 20 (3.9%) participants had results suggestive of prior hepatitis B vaccination. (biomedcentral.com)
  • People who develop antibody in response to vaccination are protected from both acute and chronic hepatitis if they experience an exposure to these viruses after vaccination. (healthywomen.org)
  • The Advisory Committee on Immunization Practices recommends that 'at-risk' infants, or infants of parents requesting vaccination, undergo hepatitis A vaccination at age 1. (healthywomen.org)
  • Targeted vaccination for opiate users against hepatitis B is more successful than previously shown in Ireland. (drugsandalcohol.ie)
  • Vaccination is protective and postexposure use of hepatitis B immune globulin may prevent or attenuate clinical disease. (msdmanuals.com)
  • free hepatitis B vaccination for newborn infants was carried out in 2001. (who.int)
  • The target groups were those who had not completed a three-dose vaccination series or who had never received hepatitis B immunization. (who.int)
Viral18
  • Serum specimens are processed, stored, and shipped to the Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. (cdc.gov)
  • FDA- approved Chemiluminescent Acridinium Ester technology provides superior sensitivity and specificity to detect antibodies to sexually transmitted viral infections. (usbiotek.com)
  • HCV was first recognised in 1970 and described as non-A, non-B hepatitis, until 1989 when the pathogen was identified as hepatitis C. The structural proteins produced by Hepatitis C virus include the core protein and envelope glycoproteins E1 and E2, which are necessary for viral entry into host cells. (thenativeantigencompany.com)
  • it is a type of viral hepatitis. (wikipedia.org)
  • Using antiviral prophylaxis to prevent mother-to-child transmission is also recommended, as is following safe sex practices, including the use of condoms In 2016, the WHO set a goal of eliminating viral hepatitis as a threat to global public health by 2030. (wikipedia.org)
  • Acute infection with hepatitis B virus is associated with acute viral hepatitis, an illness that begins with general ill-health, loss of appetite, nausea, vomiting, body aches, mild fever, and dark urine, and then progresses to development of jaundice. (wikipedia.org)
  • This pattern are different from those of massive and submassive necroses found in ordinary fulminant viral hepatitis. (scielo.br)
  • Morula-like cells" were more frequently found in HDV acute superinfection, as well as in HAV/HBV acute coinfection and acute HCV infection, and less often in other forms of viral hepatitis. (scielo.br)
  • On clinical grounds, it is hugely difficult to tell Hepatitis B from other hepatitis cases due to viral agents and, hence, laboratory confirmation of the diagnosis is essential. (apollohospitals.com)
  • VLPs are highly immunogenic and can induce elevated titers of neutralizing antibodies, even without adjuvants, thanks to the maintenance of the native conformation of viral proteins presenting repetitive epitopes to the host immune system cells. (nature.com)
  • Hepatitis B is a serious viral infection that affects the liver. (metropolisindia.com)
  • Acute hepatitis B infection is a serious viral infection that can cause liver damage. (metropolisindia.com)
  • Hepatitis B is a viral infection caused by the hepatitis B virus (HBV) which leads to acute and chronic liver disease. (biomedcentral.com)
  • You've probably heard warnings about hepatitis, a category of viral infections that can cause serious liver damage and even lead to death. (healthywomen.org)
  • Its has a good anti-viral activity against hepatitis B virus. (scialert.net)
  • The infective particle consists of a viral core plus an outer surface coat. (msdmanuals.com)
  • Overview of Acute Viral Hepatitis Acute viral hepatitis is diffuse liver inflammation caused by specific hepatotropic viruses that have diverse modes of transmission and epidemiologies. (msdmanuals.com)
  • Hepatitis A Hepatitis A is caused by an enterically transmitted RNA virus that, in older children and adults, causes typical symptoms of viral hepatitis, including anorexia, malaise, and jaundice. (msdmanuals.com)
Anti-HBs3
  • A "positive" or "reactive" HBsAb (or anti-HBs) test result indicates that a person has either successfully responded to the hepatitis B vaccine or has recovered from an acute hepatitis B infection. (hepb.org)
  • Anti-HBs: Antibodies to hepatitis B surface. (wjgnet.com)
  • For hepatitis B surface antibody (anti-HBs), a level less than 5 mIU is considered negative, while a level more than 12 mIU is considered protective. (medscape.com)
Surface antigens2
  • Attempts to detect hepatitis B antigen in faeces and bile should take into account the degradation and disappearance of the surface antigens in an environment containing proteolytic enzymes in the presence of bile salts as in the intestinal lumen. (bmj.com)
  • The cores of the Dane particles are much more stable than the surface antigens and these may best be identified by immune electron microscopy using core antibody. (bmj.com)
Total antibody1
  • Serological methods to detect HCV IgM antibodies in patient's serum are reported to be unreliable but diagnostic methods to detect HCV total antibody and HCV core protein may have some value. (thenativeantigencompany.com)
HBsAb2
Native Antigen Company1
Virus Core antibody1
Vaccines6
  • Achieving this goal would require the development of therapeutic treatments to cure chronic hepatitis B, as well as preventing its transmission and using vaccines to prevent new infections. (wikipedia.org)
  • For pregnancy, those include hepatitis A and meningococcal vaccines, which I'll not go into today. (cdc.gov)
  • Vaccines recommended during pregnancy that are in yellow across these two slides include hepatitis B, COVID-19, influenza, and Tdap. (cdc.gov)
  • Although the assembled VLPs do not have S protein spikes, they could be developed as formulations that can improve the immunogenicity of vaccines including S antigens, and further could be used as platforms that can carry S antigens of concern for various mutations. (nature.com)
  • During this SARS-CoV-2 pandemic, many studies on the development of plant-derived vaccines and antibodies are underway. (nature.com)
  • The good news is that there are vaccines against hepatitis A and hepatitis B. The vaccines are safe and effective. (healthywomen.org)
Viruses10
  • Hepatitis viruses constitute a major public health problem because of the morbidity and mortality associated with the acute and chronic consequences of these infections. (cdc.gov)
  • In addition, NHANES provides the means to better define the epidemiology of other hepatitis viruses. (cdc.gov)
  • NHANES testing for markers of infection with hepatitis viruses will be used to determine secular trends in infection rates across most age and racial/ethnic groups, and will provide a national picture of the epidemiologic determinants of these infections. (cdc.gov)
  • Hepatitis B virus (HBV) is a small, partially double-stranded DNA virus that belongs to the genus O rthohepadnaviruses of the Hepadnaviridae family of viruses. (thenativeantigencompany.com)
  • Other tests look for antigens or the genetic material ( DNA or RNA ) of the viruses that cause hepatitis. (healthlinkbc.ca)
  • It is one of five main hepatitis viruses: A, B, C, D, and E. During an initial infection, care is based on a person's symptoms. (wikipedia.org)
  • Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990- 2000. (medigraphic.com)
  • The hepatitis viruses all cause acute inflammation of the liver, and some infections related to hepatitis B and C may become chronic. (healthywomen.org)
  • All of the hepatitis viruses can cause acute hepatitis, which, in adults, usually resolves on its own over time. (healthywomen.org)
  • In contrast, the hepatitis B and C viruses may not go away and may evolve to a chronic ongoing infection. (healthywomen.org)
Hepatocellular carcinoma4
Immune globulin1
  • All pregnant women in the United States should be screened for hepatitis B. If infected, the baby will need to receive specific hepatitis B immune globulin and be vaccinated at birth. (healthywomen.org)
Cirrhosis and liver cancer1
Infections6
Serologic1
  • Levels of alanine aminotransferase (ALT) and hepatitis B virus (HBV) serologic markers and detection of HBV DNA in baboon 2. (cdc.gov)
Monoclonal antibody1
Risk of hepatitis1
Diagnosis7
  • The asymptomatic nature of HBV infection, and the similarity of clinical symptoms to other types of hepatitis virus infection makes clinical diagnosis difficult. (thenativeantigencompany.com)
  • Understanding your hepatitis B blood test results can be confusing, so you want to be sure about your diagnosis - are you infected with hepatitis B, have you recovered from a hepatitis B infection, or do you have a chronic hepatitis B infection? (hepb.org)
  • Clinicians should assess all patients with a confirmed diagnosis of chronic HCV infection, defined as a positive HCV surface antibody test result and detectable HCV RNA, for treatment. (hivguidelines.org)
  • However, Hepatitis C virus is difficult to isolate, and the asymptomatic nature of HCV infection makes clinical diagnosis difficult. (thenativeantigencompany.com)
  • Hepatitis C virus: Virology, diagnosis and treatment. (thenativeantigencompany.com)
  • The diagnosis is usually confirmed by testing the blood for parts of the virus and for antibodies against the virus. (wikipedia.org)
  • Wai, C.-T. Abstract: We present an unusual case of percutaneous liver biopsy complicated by delayed haemothorax in a 55-year-old Chinese man with hepatitis C cirrhosis and severe haemophilia A. The patient presented ten days after the initial liver biopsy, and was managed with prompt investigations for confirming the diagnosis, infusion of factor VIII and fresh frozen plasma, and early referral to the surgeon for consideration of surgical repair. (nus.edu.sg)
Symptoms9
Caused by the hepatitis B vir3
  • Hepatitis B is a disease caused by the hepatitis B virus (HBV), which is transmitted through percutaneous (i.e., puncture through the skin) or mucosal (i.e., direct contact with mucous membranes) exposure to infectious blood or body fluids. (cdc.gov)
  • Hepatitis B is a serious potentially fatal hepatocellular disease caused by the hepatitis B virus. (biomedcentral.com)
  • Hepatitis B is a liver disease caused by the hepatitis B virus that ranges from an acute mild illness lasting for a few weeks to a serious chronic illness that can eventually lead to liver disease or cancer. (healthywomen.org)
Asymptomatic2
  • Chronic infection with hepatitis B virus may be asymptomatic or may be associated with chronic inflammation of the liver (chronic hepatitis), leading to cirrhosis over a period of several years. (wikipedia.org)
  • Patients with chronic hepatitis B infection can be immune tolerant or have an inactive chronic infection without any evidence of active disease, and they are also asymptomatic. (medscape.com)
Donor1
  • Allogeneic transplants are further categorized by the degree of human leukocyte antigen (HLA) match between the donor and recipient. (medscape.com)
Chronic infection4
  • Hepatitis C virus (HCV) causes both acute and chronic infection. (thenativeantigencompany.com)
  • IgM antibodies against phase II antigen are the marker of the acute infection while high levels against phase I antigen indicate a chronic infection. (hindawi.com)
  • About 15 percent to 25 percent of people who are infected with hepatitis B develop chronic infection. (healthywomen.org)
  • Presence of the antigen longer than 6 months after initial exposure indicates chronic infection. (medscape.com)
Jaundice1
  • In folk medicine P. amarus has reportedly been used to treat jaundice, diabetes, otitis, diarrhoea, swelling, skin ulcer, gastrointestinal disturbances and blocks DNA polymerase in the case of hepatitis B virus during reproduction ( Oluwafemi and Debiri, 2008 ). (scialert.net)
Incidence4
  • To determine hepatitis B virus incidence, samples that were hepatitis B positive at the follow-up visit had their baseline samples tested to identify hepatitis B negative samples whose corresponding follow-up samples were thus incident cases. (biomedcentral.com)
  • Hepatitis B incidence was 10.5 cases/100PY (95% CI: 7.09-15.53). (biomedcentral.com)
  • Hepatitis B virus incidence in Lake Victoria fishing communities of Uganda is very high, particularly in the islands. (biomedcentral.com)
  • In 2009, the incidence of hepatitis A was 1 per 100,000, the lowest number ever recorded. (healthywomen.org)
Proteins3
Fulminant hepatitis4
Markers1
Inflammation1
HDAg1
  • Anti-HDV present in the sample and labeled anti-HDV antibodies compete for a fixed quantity of HDAg bound to the solid phase. (cdc.gov)
Assay2
  • Our Hepatitis C antigen is a highly purified core protein for use in assay development, vaccine research and as antigens for the preparation of specific antibodies. (thenativeantigencompany.com)
  • Antibodies to hepatitis C virus (anti-HCV) screening-test-positive with a signal to cut-off ratio predictive of a true positive as determined for the particular assay as defined by CDC. (cdc.gov)
Doses2
  • The WHO recommends the hepatitis B vaccine (available since 1982) be given to all infants preferably within 24 hours after birth, to be followed by 2 or 3 doses to complete the primary series. (apollohospitals.com)
  • According to the China Children Immunization Programme, a child must be vaccinated with three doses of the hepatitis B vaccine before reaching 12 months of age. (who.int)
Ribonucleic acid2
  • Serum HBV-DNA (hepatitis B virus deoxyribonucleic acid) and HDV-RNA (hepatitis D virus ribonucleic acid) were assayed using molecular hybridization technique, as previously described 3,18 . (scielo.br)
  • Hepatitis C virus ribonucleic acid. (cdc.gov)
Cases of acute2
Clinical4
  • Provide evidence-based clinical recommendations to support the goals of the New York State Hepatitis C Elimination Plan (NY Cures HepC) . (hivguidelines.org)
  • Similar clinical and histologic features of Labrea Hepatitis were found in northern Colombia 5 , western Venezuela 16 and Central African Republic 17 . (scielo.br)
  • DAKLINZA is indicated for use with sofosbuvir, with or without ribavirin, for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection [see DOSAGE AND ADMINISTRATION and Clinical Studies ]. (rxlist.com)
  • A case that meets the clinical case definition, is laboratory confirmed, and is not known to have chronic hepatitis C. (cdc.gov)
Specificity1
Liver disease1
Patients with chronic1
  • This guideline on pretreatment assessment of patients with chronic hepatitis C virus (HCV) was developed by the New York State Department of Health AIDS Institute (NYSDOH AI) to guide primary care providers and other practitioners in New York State in all aspects of treating and curing patients with chronic HCV. (hivguidelines.org)
Infectious3
  • The HBV virus is one of the leading causes of infectious hepatitis. (disabled-world.com)
  • Moreover, VLPs offer interesting biotechnological advantages as they can serve as scaffolds for presenting heterologous antigens capable of inducing immune responses against other infectious diseases. (nature.com)
  • We developed an Australian consensus statement with infectious diseases, hepatology, haematology and oncology specialists to inform hepatitis B screening and antiviral management for immunocompromised patients with haematological and solid organ malignancies in Australia. (monash.edu)
World health Organ1
Antiviral2
Transmission2
Neonatal1
Stages of hepatitis1
People with hepatitis2
Vaccine against hepatitis2
Adults3
  • Infection in adults can lead to chronic hepatitis in less than 5% of cases. (apollohospitals.com)
  • More than 90% of healthy adults who contract hepatitis B virus recover naturally from the virus within the first year. (apollohospitals.com)
  • The complete vaccine series induces protective antibody levels in more than 95% of infants, children and young adults and the protection lasts at least 20 years and sometimes lifelong. (apollohospitals.com)